
Novartis announces $23bn US manufacturing and R&D investment
As US President Donald Trump’s tariffs loom over the global economy, Swiss global healthcare company Novartis announced plans to expand its stateside manufacturing presence. The firm will invest $23 billion in ten facilities over five years, which includes …